CAS: 1138245-21-2 Mirogabalin besylate
Product Name: Mirogabalin besylate
Synonyms: Mirogabalin besylate;Mirogabalin besylat;Mirogabalin Besilate;MIROGABALIN BENZENESULFONIC ACID;((1R,5S,6S)-6-(carboxymethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)methanaminium benzenesulfonate;[(1R,5S,6S)-6-(Aminomethyl)-3-ethylbicyclo[3.2.0] hept-3-en-6-yl]acetic acid benzenesulfonate;2-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid compound with benzenesulfonic acid (1:1);Mirogabalin Besylate 10928
CAS: 1138245-21-2
MF: C18H25NO5S
MW: 367.46
Price on request
REQUEST NOWProduct Introduction:
Description: Mirogabalin besylate (mirogabalin, Tarlige) is a gabapentinoid therapy developed by Daiichi Sankyo, which is approved in Japan for the treatment of postherpetic neuralgia and painful diabetic peripheral neuropathy. Mirogabalin has a potent pain-modulating effect with a unique high affinity and prolonged dissociation rate for the a2delta-1 subunit of voltage-gated calcium (Ca2+) channels (VGCCs) on the dorsal root ganglion resulting in more sustained analgesia compared with traditional gabapentinoids
Related products